Form Type: 4

SEC EDGAR Link
Accession Number:0000947871-23-000205
Date:2023-02-15
Issuer: DISC MEDICINE, INC. (IRON)
Original Submission Date:

Reporting Person:

ORBIMED ADVISORS LLC
601 LEXINGTON AVENUE
54TH FLOOR NEW YORK, NY 10022

Reporting Person:

ORBIMED CAPITAL GP VI LLC
601 LEXINGTON AVENUE
54TH FLOOR NEW YORK, NY 10022

Reporting Person:

ORBIMED CAPITAL GP VIII LLC
601 LEXINGTON AVENUE
54TH FLOOR NEW YORK, NY 10022

Reporting Person:

ORBIMED GENESIS GP LLC
601 LEXINGTON AVENUE
54TH FLOOR NEW YORK, NY 10022

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-02-15 P 57,318 a $23.00 1,196,825 indirect
COMMON STOCK 2023-02-15 P 37,049 a $23.00 773,607 indirect
COMMON STOCK 2023-02-15 P 14,329 a $23.00 299,205 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these shares of the issuer's common stock were purchased in a registered direct offering.
f2 these securities are held of record by orbimed private investments viii, lp ("opi viii"). orbimed capital gp viii llc ("gp viii") is the general partner of opi viii and orbimed advisors llc ("orbimed advisors") is the managing member of gp viii. by virtue of such relationships, gp viii and orbimed advisors may be deemed to have voting power and investment power over the securities held by opi viii and as a result, may be deemed to have beneficial ownership over such securities. orbimed advisors exercises voting and investment power through a management committee comprised of carl l. gordon, sven h. borho, and w. carter neild, each of whom disclaims beneficial ownership of the shares held by opi viii.
f3 these securities are held of record by orbimed private investments vi, lp ("opi vi"). orbimed capital gp vi llc ("gp vi") is the general partner of opi vi and orbimed advisors is the managing member of gp vi. by virtue of such relationships, gp vi and orbimed advisors may be deemed to have voting power and investment power over the securities held by opi vi and as a result, may be deemed to have beneficial ownership over such securities. orbimed advisors exercises voting and investment power through a management committee comprised of carl l. gordon, sven h. borho, and w. carter neild, each of whom disclaims beneficial ownership of the shares held by opi vi.
f4 these securities are held of record by orbimed genesis master fund, l.p. ("genesis"). orbimed genesis gp llc ("genesis gp") is the general partner of genesis and orbimed advisors is the managing member of genesis gp. by virtue of such relationships, genesis gp and orbimed advisors may be deemed to have voting power and investment power over the securities held by genesis and as a result, may be deemed to have beneficial ownership over such securities. orbimed advisors exercises voting and investment power through a management committee comprised of carl l. gordon, sven h. borho, and w. carter neild, each of whom disclaims beneficial ownership of the shares held by genesis.
f5 this report on form 4 is jointly filed by orbimed advisors, gp viii, gp vi, and genesis gp. each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of rule 16a-1(a) under the securities exchange act of 1934, as amended (the "exchange act"), except to the extent of its pecuniary interest therein, if any. the reporting persons have designated a representative, mona ashiya, an employee of orbimed advisors, to serve on the issuer's board of directors. this report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of section 16 of the exchange act, or for any other purpose.
WhaleWisdom Logo

Elevate your investments